HUT65849A - Process for preparation of pharmaceutical compositions containing hydroxylated derivatives of doxazosin - Google Patents
Process for preparation of pharmaceutical compositions containing hydroxylated derivatives of doxazosinInfo
- Publication number
- HUT65849A HUT65849A HU9300947A HU9300947A HUT65849A HU T65849 A HUT65849 A HU T65849A HU 9300947 A HU9300947 A HU 9300947A HU 9300947 A HU9300947 A HU 9300947A HU T65849 A HUT65849 A HU T65849A
- Authority
- HU
- Hungary
- Prior art keywords
- doxazosin
- preparation
- pharmaceutical compositions
- compositions containing
- hydroxylated derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/15—Details of package parts other than the semiconductor or other solid state devices to be connected
- H01L2924/181—Encapsulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86171492A | 1992-04-01 | 1992-04-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9300947D0 HU9300947D0 (en) | 1993-06-28 |
HUT65849A true HUT65849A (en) | 1994-07-28 |
HU225113B1 HU225113B1 (en) | 2006-06-28 |
Family
ID=25336560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9300947A HU225113B1 (en) | 1992-04-01 | 1993-03-31 | Process for preparation of pharmaceutical compositions for the treatment of vascular deseases containing hydroxylated derivatives of doxazosin |
Country Status (17)
Country | Link |
---|---|
US (1) | US5543411A (hu) |
EP (1) | EP0564093B1 (hu) |
JP (1) | JPH0624989A (hu) |
KR (1) | KR0137927B1 (hu) |
AT (1) | ATE187069T1 (hu) |
AU (1) | AU660359B2 (hu) |
CA (1) | CA2092983C (hu) |
DE (1) | DE69327128T2 (hu) |
DK (1) | DK0564093T3 (hu) |
ES (1) | ES2139624T3 (hu) |
GR (1) | GR3032373T3 (hu) |
HU (1) | HU225113B1 (hu) |
IL (1) | IL105141A (hu) |
MX (1) | MX9301824A (hu) |
NZ (1) | NZ247307A (hu) |
PT (1) | PT564093E (hu) |
ZA (1) | ZA932307B (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL120302A0 (en) * | 1996-03-27 | 1997-06-10 | Pfizer | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
US6177430B1 (en) | 1997-03-27 | 2001-01-23 | Pfizer Inc | Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
IL120303A0 (en) * | 1996-03-27 | 1997-06-10 | Pfizer | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer |
WO2002024114A2 (en) * | 2000-09-25 | 2002-03-28 | Cohesion Technologies, Inc. | Resorbable anastomosis stents and plugs |
US20050165428A1 (en) * | 2000-09-25 | 2005-07-28 | Franco Kenneth L. | Absorable surgical structure |
KR101119387B1 (ko) | 2003-07-18 | 2012-03-07 | 하마마츠 포토닉스 가부시키가이샤 | 절단방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB271997A (en) * | 1926-04-16 | 1927-06-09 | Morris Engines Coventry Ltd | Improvements relating to the driving of cam or other auxiliary shafts in internal combustion engines |
US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
GB8506174D0 (en) * | 1985-03-09 | 1985-04-11 | Pfizer Ltd | 4-amino-6 7-dimethoxy-2-piperazin-1-ylquinazoline derivatives |
US4758569A (en) * | 1987-08-26 | 1988-07-19 | Pfizer Inc. | Doxazosin as an anti-atherosclerosis agent |
-
1993
- 1993-02-26 PT PT93301505T patent/PT564093E/pt unknown
- 1993-02-26 DE DE69327128T patent/DE69327128T2/de not_active Expired - Fee Related
- 1993-02-26 EP EP93301505A patent/EP0564093B1/en not_active Expired - Lifetime
- 1993-02-26 DK DK93301505T patent/DK0564093T3/da active
- 1993-02-26 ES ES93301505T patent/ES2139624T3/es not_active Expired - Lifetime
- 1993-02-26 AT AT93301505T patent/ATE187069T1/de not_active IP Right Cessation
- 1993-03-23 IL IL10514193A patent/IL105141A/en not_active IP Right Cessation
- 1993-03-30 MX MX9301824A patent/MX9301824A/es unknown
- 1993-03-30 CA CA002092983A patent/CA2092983C/en not_active Expired - Fee Related
- 1993-03-31 HU HU9300947A patent/HU225113B1/hu not_active IP Right Cessation
- 1993-03-31 AU AU35629/93A patent/AU660359B2/en not_active Ceased
- 1993-03-31 ZA ZA932307A patent/ZA932307B/xx unknown
- 1993-03-31 NZ NZ247307A patent/NZ247307A/en not_active IP Right Cessation
- 1993-03-31 JP JP5074262A patent/JPH0624989A/ja active Pending
- 1993-03-31 KR KR1019930005409A patent/KR0137927B1/ko not_active IP Right Cessation
-
1995
- 1995-05-08 US US08/436,787 patent/US5543411A/en not_active Expired - Lifetime
-
2000
- 2000-01-14 GR GR20000400072T patent/GR3032373T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0564093T3 (da) | 2000-03-27 |
HU225113B1 (en) | 2006-06-28 |
IL105141A0 (en) | 1993-07-08 |
AU3562993A (en) | 1993-10-07 |
MX9301824A (es) | 1994-02-28 |
ATE187069T1 (de) | 1999-12-15 |
JPH0624989A (ja) | 1994-02-01 |
KR930021203A (ko) | 1993-11-22 |
HU9300947D0 (en) | 1993-06-28 |
US5543411A (en) | 1996-08-06 |
DE69327128D1 (de) | 2000-01-05 |
GR3032373T3 (en) | 2000-04-27 |
CA2092983A1 (en) | 1993-10-02 |
AU660359B2 (en) | 1995-06-22 |
CA2092983C (en) | 1996-12-31 |
NZ247307A (en) | 1997-06-24 |
ES2139624T3 (es) | 2000-02-16 |
PT564093E (pt) | 2000-04-28 |
ZA932307B (en) | 1994-09-30 |
EP0564093A1 (en) | 1993-10-06 |
IL105141A (en) | 1998-10-30 |
DE69327128T2 (de) | 2000-04-20 |
EP0564093B1 (en) | 1999-12-01 |
KR0137927B1 (ko) | 1998-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL305092A1 (en) | Novel derivatives of 11-benzaldoxim estradiene, method of obtaining them and therapeutic agents containing such compounds | |
PT80773A (en) | Process for the preparation of substituted benzoate ester prodrug derivatives of 3-hydroxymorfinans intermediates thereto and of pharmaceutical compositions containing the same | |
GR880100491A (en) | Method for the preparation of aketaminophane formulations orally slowly released | |
GR3020843T3 (en) | Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids | |
AU4519389A (en) | Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions | |
GR3018212T3 (en) | Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them. | |
HUT51141A (en) | Process for production of medical composition against arteriosclerosis containing doxasosine | |
HUT68315A (en) | New 11-benzaldoxime-17-beta-methoxy-17-alpha-methoxy-methyl-estradiene derivatives, pharmaceutical compositions containing them and process for producing them | |
HUT65849A (en) | Process for preparation of pharmaceutical compositions containing hydroxylated derivatives of doxazosin | |
AU3407093A (en) | Process for the production of pharmaceutically acceptable salts of clavulanic acid | |
GB2246351B (en) | Preparation of methoxyphenyl-glycidic acid esters useful for the synthesis of benzothiazepines | |
IL86745A0 (en) | Analgesic compositions containing derivatives of dioxopiperidine | |
GR3017599T3 (en) | Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them. | |
NO930183D0 (no) | Fremgagsmaate for fremstilling av et komposittprodukt ved stoeping | |
HUT35518A (en) | Process for producing new oral pharmaceutical galenic compositions containing n-/1-ethyl-2-pyrrolidinylmethyl/-2-methoxy-5-sulfamoyl-benzamide /sulpiride/ | |
HUT58205A (en) | Process for producing pharmaceutical compositions containing pharmaceutically active organosilane derivatives | |
PL314005A1 (en) | Method of obtaining orally administered compositions containing quinolones | |
HUT39415A (en) | Process for producing new n-/2-hydroxy-alkyi/-amino-acids and derivatives and pharmaceutical compositions containing them as active agents | |
FI922518A0 (fi) | Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi | |
HU911749D0 (en) | Process for the preparation of a vasodilator composition | |
HUT50806A (en) | Process for producing new labdane derivatives and pharmaceutical compositions comprising such compounds | |
GB8811448D0 (en) | Novel anti-inflammatory agents pharmaceutical compositions & methods for reducing inflammation | |
HU9204082D0 (en) | Method for producing intermediate compounds of pharmaceutical synthesis having 16-dehydro-20-oxo-pregnane structure | |
CA2173158A1 (en) | Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |